B01. Notice of Intent to Sole Source - as of 03.12.2026.pdf

Notice of Intent (NOI) to Sole Source

Title: Malaria Radical Cure Drug Efficacy Clinical Study

Requiring Activity Name: Walter Reed Army Institute of Research (WRAIR), Armed Forces Research Institute of Medical Sciences (AFRIMS)

Related Notice: HT942526R0999

Product Service Code (PSC): AN11 – Health R&D Services; Health Care Services;

Basic Research

North American Industry Classification System (NAICS) Code: 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

The Defense Health Agency Contracting Activity (DHACA) intends to award on a sole source basis (IAW FAR 6.302-1(a)(2)(i)(A)) to The Research Foundation for The State University of New York (SUNY), 750 E Adams Street, Syracuse, NY, 13210, CAGE Code: 3GKC0, as the only responsible source that can provide the required Malaria Radical Cure Drug Efficacy Clinical Study.

Description of Services: This requirement is a non-personal services contract to conduct research for two clinical studies on the safety and efficacy of radical cure therapies against relapsing malaria caused by Plasmodium vivax in conjunction with the WRAIR-AFRIMS. This effort includes two different clinical studies with two phases. One clinical study to measure the safety and pharmacokinetics of tafenoquine in healthy adults to be carried out in the U.S., and a second clinical study to measure the efficacy of the tafenoquine in treating malaria in an endemic area in Thailand.

This special notice of intent is not a request for competitive proposals, and no solicitation document exists for this requirement. Meaningful submissions received in response to this notice will be considered solely for the purpose of determining whether a competitive procurement is in the best interest of the Government.

If no meaningful, written submissions are received by the date listed below, after the publication of this notice, the solicitation will be issued as a sole source requirement to The Research Foundation for The State University of New York (SUNY). Based on the above information, the only technically acceptable vendor to conduct the Malaria Radical Cure Drug Efficacy Clinical Study can be provided by the Research Foundation for The State University of New York (SUNY).

Submit capability statements (using PDF, MS Word, or Excel attachments) to Ashley Atkins at email: ashley.n.atkins.civ@health.mil.

Capability statements are due by 08:00 AM EDT on Saturday, 25 April 2026. No phone calls are accepted.

mailto:email:%20ashley.n.atkins.civ@health.mil